Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shilpa Medicare Limited ( (IN:SHILPAMED) ) just unveiled an announcement.
Shilpa Medicare Limited has announced that it will release its second-quarter earnings results for the fiscal year 2026 on November 13, 2025, with an earnings call scheduled for November 17, 2025. This announcement is significant as it provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
More about Shilpa Medicare Limited
Shilpa Medicare Limited is an integrated pharmaceutical group specializing in niche Oncology and Non-oncology APIs, Peptides, Polymers, and differentiated finished dosage formulations such as orally dispersible films and transdermal patches. The company also offers comprehensive CDMO services to global pharmaceutical firms, leveraging its robust R&D and manufacturing capabilities, supported by four R&D units and seven manufacturing facilities.
Average Trading Volume: 26,593
Technical Sentiment Signal: Buy
Current Market Cap: 70.06B INR
Learn more about SHILPAMED stock on TipRanks’ Stock Analysis page.